 | • レポートコード：QYR9NV05324 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ガレクチン3の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、GAL-300、GRMD-03、ANG-4021、KTI、その他に、用途別には、肝硬変、門脈圧亢進症、転移性黒色腫、その他にセグメント区分し、ガレクチン3の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ガレクチン3の世界市場概要 ・ガレクチン3の製造コスト構成分析 ・ガレクチン3の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ガレクチン3の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ガレクチン3のセグメント分析（種類別） （GAL-300、GRMD-03、ANG-4021、KTI、その他） ・ガレクチン3のセグメント分析（用途別） （肝硬変、門脈圧亢進症、転移性黒色腫、その他） ・ガレクチン3の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Angion Biomedica Corp、Bristol-Myers Squibb Company、Galectin Therapeutics Inc、GlycoMimetics Inc、iTeos Therapeutics SA、MandalMed Inc、） ・ガレクチン3の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Galectin 3 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Galectin 3 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Galectin 3 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Galectin 3 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Galectin 3 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
GAL-300
GRMD-03
ANG-4021
KTI
Others
Segment by Application
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others
Table of Contents
Executive Summary
1 Industry Overview of Galectin 3
1.1 Definition of Galectin 3
1.2 Galectin 3 Segment by Type
1.2.1 Global Galectin 3 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 GAL-300
1.2.3 GRMD-03
1.2.4 ANG-4021
1.2.5 KTI
1.2.6 Others
1.3 Galectin 3 Segment by Applications
1.3.1 Global Galectin 3 Consumption Comparison by Applications (2014-2025)
1.3.2 Liver Cirrhosis
1.3.3 Portal Hypertension
1.3.4 Metastatic Melanoma
1.3.5 Others
1.4 Global Galectin 3 Overall Market
1.4.1 Global Galectin 3 Revenue (2014-2025)
1.4.2 Global Galectin 3 Production (2014-2025)
1.4.3 North America Galectin 3 Status and Prospect (2014-2025)
1.4.4 Europe Galectin 3 Status and Prospect (2014-2025)
1.4.5 China Galectin 3 Status and Prospect (2014-2025)
1.4.6 Japan Galectin 3 Status and Prospect (2014-2025)
1.4.7 Southeast Asia Galectin 3 Status and Prospect (2014-2025)
1.4.8 India Galectin 3 Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Galectin 3
2.3 Manufacturing Process Analysis of Galectin 3
2.4 Industry Chain Structure of Galectin 3
3 Development and Manufacturing Plants Analysis of Galectin 3
3.1 Capacity and Commercial Production Date
3.2 Global Galectin 3 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Galectin 3
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Galectin 3 Production and Capacity Analysis
4.2 Galectin 3 Revenue Analysis
4.3 Galectin 3 Price Analysis
4.4 Market Concentration Degree
5 Galectin 3 Regional Market Analysis
5.1 Galectin 3 Production by Regions
5.1.1 Global Galectin 3 Production by Regions
5.1.2 Global Galectin 3 Revenue by Regions
5.2 Galectin 3 Consumption by Regions
5.3 North America Galectin 3 Market Analysis
5.3.1 North America Galectin 3 Production
5.3.2 North America Galectin 3 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Galectin 3 Import and Export
5.4 Europe Galectin 3 Market Analysis
5.4.1 Europe Galectin 3 Production
5.4.2 Europe Galectin 3 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Galectin 3 Import and Export
5.5 China Galectin 3 Market Analysis
5.5.1 China Galectin 3 Production
5.5.2 China Galectin 3 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Galectin 3 Import and Export
5.6 Japan Galectin 3 Market Analysis
5.6.1 Japan Galectin 3 Production
5.6.2 Japan Galectin 3 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Galectin 3 Import and Export
5.7 Southeast Asia Galectin 3 Market Analysis
5.7.1 Southeast Asia Galectin 3 Production
5.7.2 Southeast Asia Galectin 3 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Galectin 3 Import and Export
5.8 India Galectin 3 Market Analysis
5.8.1 India Galectin 3 Production
5.8.2 India Galectin 3 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Galectin 3 Import and Export
6 Galectin 3 Segment Market Analysis (by Type)
6.1 Global Galectin 3 Production by Type
6.2 Global Galectin 3 Revenue by Type
6.3 Galectin 3 Price by Type
7 Galectin 3 Segment Market Analysis (by Application)
7.1 Global Galectin 3 Consumption by Application
7.2 Global Galectin 3 Consumption Market Share by Application (2014-2019)
8 Galectin 3 Major Manufacturers Analysis
8.1 Angion Biomedica Corp
8.1.1 Angion Biomedica Corp Galectin 3 Production Sites and Area Served
8.1.2 Angion Biomedica Corp Product Introduction, Application and Specification
8.1.3 Angion Biomedica Corp Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Galectin 3 Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Galectin Therapeutics Inc
8.3.1 Galectin Therapeutics Inc Galectin 3 Production Sites and Area Served
8.3.2 Galectin Therapeutics Inc Product Introduction, Application and Specification
8.3.3 Galectin Therapeutics Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlycoMimetics Inc
8.4.1 GlycoMimetics Inc Galectin 3 Production Sites and Area Served
8.4.2 GlycoMimetics Inc Product Introduction, Application and Specification
8.4.3 GlycoMimetics Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 iTeos Therapeutics SA
8.5.1 iTeos Therapeutics SA Galectin 3 Production Sites and Area Served
8.5.2 iTeos Therapeutics SA Product Introduction, Application and Specification
8.5.3 iTeos Therapeutics SA Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 MandalMed Inc
8.6.1 MandalMed Inc Galectin 3 Production Sites and Area Served
8.6.2 MandalMed Inc Product Introduction, Application and Specification
8.6.3 MandalMed Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Galectin 3 Market
9.1 Global Galectin 3 Market Trend Analysis
9.1.1 Global Galectin 3 Market Size (Volume and Value) Forecast 2019-2025
9.2 Galectin 3 Regional Market Trend
9.2.1 North America Galectin 3 Forecast 2019-2025
9.2.2 Europe Galectin 3 Forecast 2019-2025
9.2.3 China Galectin 3 Forecast 2019-2025
9.2.4 Japan Galectin 3 Forecast 2019-2025
9.2.5 Southeast Asia Galectin 3 Forecast 2019-2025
9.2.6 India Galectin 3 Forecast 2019-2025
9.3 Galectin 3 Market Trend (Product Type)
9.4 Galectin 3 Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Galectin 3 Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Galectin 3
Table Global Galectin 3 Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Galectin 3 Production Market Share by Types in 2018
Figure GAL-300 Product Picture
Figure GRMD-03 Product Picture
Figure ANG-4021 Product Picture
Figure KTI Product Picture
Figure Others Product Picture
Table Global Galectin 3 Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Galectin 3 Consumption Market Share by Applications in 2018
Figure Liver Cirrhosis
Figure Portal Hypertension
Figure Metastatic Melanoma
Figure Others
Figure Global Galectin 3 Revenue (Million USD) (2014-2025)
Figure Global Galectin 3 Production (K Units) (2014-2025)
Figure North America Galectin 3 Market Size (Million USD) (2014-2025)
Figure Europe Galectin 3 Market Size (Million USD) (2014-2025)
Figure China Galectin 3 Market Size (Million USD) (2014-2025)
Figure Japan Galectin 3 Market Size (Million USD) (2014-2025)
Figure Southeast Asia Galectin 3 Market Size (Million USD) (2014-2025)
Figure India Galectin 3 Market Size (Million USD) (2014-2025)
Table Galectin 3 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Galectin 3 in 2018
Figure Manufacturing Process Analysis of Galectin 3
Figure Industry Chain Structure of Galectin 3
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Galectin 3 Manufacturing Plants Distribution
Table Galectin 3 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Galectin 3 Capacity (K Units) of Major Manufacturers (2014-2019)
Table Galectin 3 Production (K Units) of Major Manufacturers (2014-2019)
Table Galectin 3 Production Market Share of Major Manufacturers (2014-2019)
Figure Galectin 3 Production Share by Manufacturers in 2018
Table Galectin 3 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Galectin 3 Revenue Market Share of Major Manufacturers (2014-2019)
Figure Galectin 3 Revenue Share by Manufacturers in 2018
Table Galectin 3 Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Galectin 3 Production by Regions 2014-2019 (K Units)
Table Global Galectin 3 Production Market Share by Regions 2014-2019
Figure Global Galectin 3 Production Market Share by Regions in 2018
Table Global Galectin 3 Revenue by Regions 2014-2019 (Million USD)
Table Global Galectin 3 Revenue Market Share by Regions 2014-2019
Figure Global Galectin 3 Revenue Market Share by Regions in 2018
Table Global Galectin 3 Consumption by Regions 2014-2019 (K Units)
Table Global Galectin 3 Consumption Market Share by Regions 2014-2019
Figure North America Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure North America Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table North America Galectin 3 Production, Consumption Import and Export (K Units)
Figure Europe Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure Europe Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Galectin 3 Production, Consumption Import and Export (K Units)
Figure China Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure China Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table China Galectin 3 Production, Consumption Import and Export (K Units)
Figure Japan Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure Japan Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Galectin 3 Production, Consumption Import and Export (K Units)
Figure Southeast Asia Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Galectin 3 Production, Consumption Import and Export (K Units)
Figure India Galectin 3 Production Growth Rate 2014-2019 (K Units)
Figure India Galectin 3 Revenue Growth Rate 2014-2019 (Million USD)
Table India Galectin 3 Production, Consumption Import and Export (K Units)
Figure Global Consumption Galectin 3 Market Share by Application (2014-2019)
Figure Global Value (Consumption) Galectin 3 Market Share by Application (2014-2019)
Table Angion Biomedica Corp Galectin 3 Production Sites and Area Served
Table Angion Biomedica Corp Galectin 3 Product Introduction, Application and Specification
Table Angion Biomedica Corp Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Angion Biomedica Corp Galectin 3 Production Growth Rate (2014-2019)
Table Angion Biomedica Corp Galectin 3 Production Market Share (2014-2019)
Figure Angion Biomedica Corp Galectin 3 Revenue Market Share (2014-2019)
Table Angion Biomedica Corp Galectin 3 Main Business and Markets Served
Table Bristol-Myers Squibb Company Galectin 3 Production Sites and Area Served
Table Bristol-Myers Squibb Company Galectin 3 Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Galectin 3 Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Galectin 3 Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Galectin 3 Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Galectin 3 Main Business and Markets Served
Table Galectin Therapeutics Inc Galectin 3 Production Sites and Area Served
Table Galectin Therapeutics Inc Galectin 3 Product Introduction, Application and Specification
Table Galectin Therapeutics Inc Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Galectin Therapeutics Inc Galectin 3 Production Growth Rate (2014-2019)
Table Galectin Therapeutics Inc Galectin 3 Production Market Share (2014-2019)
Figure Galectin Therapeutics Inc Galectin 3 Revenue Market Share (2014-2019)
Table Galectin Therapeutics Inc Galectin 3 Main Business and Markets Served
Table GlycoMimetics Inc Galectin 3 Production Sites and Area Served
Table GlycoMimetics Inc Galectin 3 Product Introduction, Application and Specification
Table GlycoMimetics Inc Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlycoMimetics Inc Galectin 3 Production Growth Rate (2014-2019)
Table GlycoMimetics Inc Galectin 3 Production Market Share (2014-2019)
Figure GlycoMimetics Inc Galectin 3 Revenue Market Share (2014-2019)
Table GlycoMimetics Inc Galectin 3 Main Business and Markets Served
Table iTeos Therapeutics SA Galectin 3 Production Sites and Area Served
Table iTeos Therapeutics SA Galectin 3 Product Introduction, Application and Specification
Table iTeos Therapeutics SA Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table iTeos Therapeutics SA Galectin 3 Production Growth Rate (2014-2019)
Table iTeos Therapeutics SA Galectin 3 Production Market Share (2014-2019)
Figure iTeos Therapeutics SA Galectin 3 Revenue Market Share (2014-2019)
Table iTeos Therapeutics SA Galectin 3 Main Business and Markets Served
Table MandalMed Inc Galectin 3 Production Sites and Area Served
Table MandalMed Inc Galectin 3 Product Introduction, Application and Specification
Table MandalMed Inc Galectin 3 Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table MandalMed Inc Galectin 3 Production Growth Rate (2014-2019)
Table MandalMed Inc Galectin 3 Production Market Share (2014-2019)
Figure MandalMed Inc Galectin 3 Revenue Market Share (2014-2019)
Table MandalMed Inc Galectin 3 Main Business and Markets Served
Figure Global Galectin 3 Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Galectin 3 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Galectin 3 Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Galectin 3 Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Galectin 3 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Galectin 3 by Type (2019-2025)
Table Global Consumption (K Units) of Galectin 3 by Application (2019-2025)
Table Galectin 3 Distributors List
Table Galectin 3 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
腎線維症治療のグローバル市場調査 2019年 The global Kidney (Renal) Fibrosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Kidney (Renal) Fibrosis volume and value at global level, regional level and company level. From a global perspecti…- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 肝硬変の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. Scope of the Report: This report focuses on the Liver Cirrhosis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East an…